Literature DB >> 19556311

Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS.

L Strober1, J Englert, F Munschauer, B Weinstock-Guttman, S Rao, R H B Benedict.   

Abstract

BACKGROUND: Cognitive impairment is common in multiple sclerosis (MS) affecting roughly 45-60% of patients. Because memory deficits have significant impact on employment, caregiver burden, and social functioning, neuropsychological (NP) assessment is often recommended. Two widely used and validated NP batteries for MS are the Rao Brief Repeatable Neuropsychological Battery (BRNB) and the Minimal Assessment of Cognitive Function in MS (MACFIMS). Although similar, these batteries differ in the specific auditory/verbal and visual/spatial memory tests employed. The relative sensitivity of these memory tests is unknown.
METHODS: The BRNB and MACFIMS have considerable overlap but different memory tests: the former includes the Selective Reminding Test (SRT) and the 10/36 Spatial Recall Test (10/36) and the latter the California Verbal Learning Test, Second Edition (CVLT2) and Brief Visuospatial Memory Test, Revised (BVMTR). In 65 patients with MS and 46 demographically matched controls, we compared the sensitivity of these tests, and secondarily their respective batteries.
RESULTS: The BRNB and MACFIMS were comparable in their overall sensitivity to disease status. Although the BVMTR showed greater discriminative validity than the 10/36, the CVLT2 and SRT were comparable in sensitivity. The SDMT was the most sensitive NP test across both batteries.
CONCLUSIONS: We conclude that the BRNB and MACFIMS have comparable sensitivity among patients with MS. The sensitivity of the auditory/verbal memory tests from these batteries is similar, but the BVMTR appears to be more sensitive than the 10/36. Clinical implications are discussed.

Entities:  

Mesh:

Year:  2009        PMID: 19556311     DOI: 10.1177/1352458509106615

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  50 in total

1.  Validity of a computerized version of the symbol digit modalities test in multiple sclerosis.

Authors:  Nadine Akbar; Kimia Honarmand; Nancy Kou; Anthony Feinstein
Journal:  J Neurol       Date:  2010-10-06       Impact factor: 4.849

2.  Neurosonological and cognitive screening for evaluation of systemic sclerosis patients.

Authors:  B R Sakr; R E Rabea; A M Aboulfotooh; N A Kishk
Journal:  Clin Rheumatol       Date:  2019-02-26       Impact factor: 2.980

3.  APOE epsilon4 and the cognitive genetics of multiple sclerosis.

Authors:  O Ghaffar; M Reis; N Pennell; P O'Connor; A Feinstein
Journal:  Neurology       Date:  2010-05-18       Impact factor: 9.910

Review 4.  Secondary Progressive Multiple Sclerosis: Definition and Measurement.

Authors:  Domenico Plantone; Floriana De Angelis; Anisha Doshi; Jeremy Chataway
Journal:  CNS Drugs       Date:  2016-06       Impact factor: 5.749

5.  Regression-Based Norms for the Symbol Digit Modalities Test in the Dutch Population: Improving Detection of Cognitive Impairment in Multiple Sclerosis?

Authors:  Jessica Burggraaff; Dirk L Knol; Bernard M J Uitdehaag
Journal:  Eur Neurol       Date:  2017-03-21       Impact factor: 1.710

6.  Speech and pause characteristics in multiple sclerosis: a preliminary study of speakers with high and low neuropsychological test performance.

Authors:  Lynda Feenaughty; Kris Tjaden; Ralph H B Benedict; Bianca Weinstock-Guttman
Journal:  Clin Linguist Phon       Date:  2013-02       Impact factor: 1.346

7.  Robust perfusion deficits in cognitively impaired patients with secondary-progressive multiple sclerosis.

Authors:  P L Francis; R Jakubovic; P O'Connor; L Zhang; A Eilaghi; L Lee; T J Carroll; J Mouannes-Srour; A Feinstein; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2012-06-14       Impact factor: 3.825

8.  Identification and clinical impact of multiple sclerosis cortical lesions as assessed by routine 3T MR imaging.

Authors:  A Mike; B I Glanz; P Hildenbrand; D Meier; K Bolden; M Liguori; E Dell'Oglio; B C Healy; R Bakshi; C R G Guttmann
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-10       Impact factor: 3.825

Review 9.  Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis.

Authors:  Regina Berkovich; Mark A Agius
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

10.  Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.

Authors:  Simone Migliore; Anna Ghazaryan; Ilaria Simonelli; Patrizio Pasqualetti; Doriana Landi; Maria Giuseppina Palmieri; Filomena Moffa; Pasquale Rinaldi; Fabrizio Vernieri; Maria Maddalena Filippi
Journal:  Neurol Sci       Date:  2016-04-20       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.